Pharmacological treatment of asthma today

Rabe K.F., Schmidt D.T.

Source: Eur Respir J 2001; 18: 34S-40S
Journal Issue: July 2001 - Suppl. 34
Disease area: Airway diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Rabe K.F., Schmidt D.T.. Pharmacological treatment of asthma today. Eur Respir J 2001; 18: 34S-40S

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Treatment of asthma the current European perspective
Source: Annual Congress 2006 - Childhood asthma therapy: where we are now and where we need to go
Year: 2006

Asthma in children
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=278
Year: 2003

Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness
Source: Eur Respir J 2006; 27: 1144-1151
Year: 2006

The in vitro profile of ADC3680, a potent and selective CRTh2 antagonist for the treatment of inadequately controlled asthma
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013

Pharmacological agents used to treat asthma
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=339
Year: 2003

First line anti-inflammatory treatment for asthma: inhaled steroid or leukotriene antagonist?
Source: Eur Respir J 2002; 20: Suppl. 38, 93s
Year: 2002

Use of anti-inflammatory therapy and asthma mortality in Japan
Source: Eur Respir J 2003; 21: 101-104
Year: 2003

Interaction between the Arg16 homozygous genotype, inhaled corticosteroids and long acting beta agonists for asthma exacerbations in children? Leukotriene receptor antagonists to the rescue?
Source: Annual Congress 2013 –Asthma and lung development: from genes to environment
Year: 2013

Bronchodilator effect of a novel inhaled dual PDE3/4 inhibitor, RPL554, in mild allergic asthma & rhinitis
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013

Side effects of the leukotriene receptor antagonists in asthmatic children
Source: International Congress 2014 – Asthma and COPD devices and treatments
Year: 2014

Efficacy and safety of abediterol, a long-acting beta2-adrenergic agonist (LABA); three phase II trials in asthma
Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases
Year: 2014

The inverse agonist propranolol does not confer steroid-sparing activity in persistent asthma
Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases
Year: 2014

Beta agonists, inhaled steroids, and the risk of intensive care unit admission for asthma
Source: Eur Respir J 2001; 17: 233-240
Year: 2001

Fevipiprant, an oral prostaglandin DP2 receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids
Source: Eur Respir J, 50 (2) 1700670; 10.1183/13993003.00670-2017
Year: 2017

Real-life use and impact of inhaled steroids (ICS) and leukotriene receptor antagonists (LTRA) monotherapy in children with asthma
Source: Annual Congress 2010 - Paediatric asthma treatment and monitoring
Year: 2010

LATE-BREAKING ABSTRACT: Anti-inflammatory effect of a novel inhaled dual PDE3/4 inhibitor RPL554 in man, a unique “first-in-class” drug for the treatment of COPD & asthma
Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment
Year: 2013

Long-acting beta2 agonist without concomitant inhaled corticosteroids in children with asthma in primary care
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014

Factors influencing the relative effect of leukotriene receptor antagonists (LTRA) and inhaled corticosteroids (ICS) as monotherapy in persistent asthma: A systematic review
Source: Annual Congress 2011 - Asthma management and response
Year: 2011

Pharmacological treatment of severe, therapy-resistant asthma in children: what can we learn from where?
Source: Eur Respir J 2011; 38: 947-958
Year: 2011

Severe therapy resistant asthma
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=312
Year: 2003